Cargando…

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes

Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbańczyk, Kamila, Guntschnig, Sonja, Antoniadis, Vasilis, Falamic, Slaven, Kovacevic, Tijana, Kurczewska-Michalak, Marta, Miljković, Branislava, Olearova, Anna, Sviestina, Inese, Szucs, Attila, Tachkov, Konstantin, Tiszai, Zita, Volmer, Daisy, Wiela-Hojeńska, Anna, Fialova, Daniela, Vlcek, Jiri, Stuhec, Matej, Hogg, Anita, Scott, Michael, Stewart, Derek, Mair, Alpana, Ravera, Silvia, Lery, François-Xavier, Kardas, Przemysław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433912/
https://www.ncbi.nlm.nih.gov/pubmed/37601045
http://dx.doi.org/10.3389/fphar.2023.1244151
_version_ 1785091757072973824
author Urbańczyk, Kamila
Guntschnig, Sonja
Antoniadis, Vasilis
Falamic, Slaven
Kovacevic, Tijana
Kurczewska-Michalak, Marta
Miljković, Branislava
Olearova, Anna
Sviestina, Inese
Szucs, Attila
Tachkov, Konstantin
Tiszai, Zita
Volmer, Daisy
Wiela-Hojeńska, Anna
Fialova, Daniela
Vlcek, Jiri
Stuhec, Matej
Hogg, Anita
Scott, Michael
Stewart, Derek
Mair, Alpana
Ravera, Silvia
Lery, François-Xavier
Kardas, Przemysław
author_facet Urbańczyk, Kamila
Guntschnig, Sonja
Antoniadis, Vasilis
Falamic, Slaven
Kovacevic, Tijana
Kurczewska-Michalak, Marta
Miljković, Branislava
Olearova, Anna
Sviestina, Inese
Szucs, Attila
Tachkov, Konstantin
Tiszai, Zita
Volmer, Daisy
Wiela-Hojeńska, Anna
Fialova, Daniela
Vlcek, Jiri
Stuhec, Matej
Hogg, Anita
Scott, Michael
Stewart, Derek
Mair, Alpana
Ravera, Silvia
Lery, François-Xavier
Kardas, Przemysław
author_sort Urbańczyk, Kamila
collection PubMed
description Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.
format Online
Article
Text
id pubmed-10433912
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104339122023-08-18 Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes Urbańczyk, Kamila Guntschnig, Sonja Antoniadis, Vasilis Falamic, Slaven Kovacevic, Tijana Kurczewska-Michalak, Marta Miljković, Branislava Olearova, Anna Sviestina, Inese Szucs, Attila Tachkov, Konstantin Tiszai, Zita Volmer, Daisy Wiela-Hojeńska, Anna Fialova, Daniela Vlcek, Jiri Stuhec, Matej Hogg, Anita Scott, Michael Stewart, Derek Mair, Alpana Ravera, Silvia Lery, François-Xavier Kardas, Przemysław Front Pharmacol Pharmacology Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region. Frontiers Media S.A. 2023-08-02 /pmc/articles/PMC10433912/ /pubmed/37601045 http://dx.doi.org/10.3389/fphar.2023.1244151 Text en Copyright © 2023 Urbańczyk, Guntschnig, Antoniadis, Falamic, Kovacevic, Kurczewska-Michalak, Miljković, Olearova, Sviestina, Szucs, Tachkov, Tiszai, Volmer, Wiela-Hojeńska, Fialova, Vlcek, Stuhec, Hogg, Scott, Stewart, Mair, Ravera, Lery and Kardas. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Urbańczyk, Kamila
Guntschnig, Sonja
Antoniadis, Vasilis
Falamic, Slaven
Kovacevic, Tijana
Kurczewska-Michalak, Marta
Miljković, Branislava
Olearova, Anna
Sviestina, Inese
Szucs, Attila
Tachkov, Konstantin
Tiszai, Zita
Volmer, Daisy
Wiela-Hojeńska, Anna
Fialova, Daniela
Vlcek, Jiri
Stuhec, Matej
Hogg, Anita
Scott, Michael
Stewart, Derek
Mair, Alpana
Ravera, Silvia
Lery, François-Xavier
Kardas, Przemysław
Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
title Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
title_full Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
title_fullStr Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
title_full_unstemmed Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
title_short Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes
title_sort recommendations for wider adoption of clinical pharmacy in central and eastern europe in order to optimise pharmacotherapy and improve patient outcomes
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433912/
https://www.ncbi.nlm.nih.gov/pubmed/37601045
http://dx.doi.org/10.3389/fphar.2023.1244151
work_keys_str_mv AT urbanczykkamila recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT guntschnigsonja recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT antoniadisvasilis recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT falamicslaven recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT kovacevictijana recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT kurczewskamichalakmarta recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT miljkovicbranislava recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT olearovaanna recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT sviestinainese recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT szucsattila recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT tachkovkonstantin recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT tiszaizita recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT volmerdaisy recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT wielahojenskaanna recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT fialovadaniela recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT vlcekjiri recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT stuhecmatej recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT hogganita recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT scottmichael recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT stewartderek recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT mairalpana recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT raverasilvia recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT leryfrancoisxavier recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes
AT kardasprzemysław recommendationsforwideradoptionofclinicalpharmacyincentralandeasterneuropeinordertooptimisepharmacotherapyandimprovepatientoutcomes